Company Overview

Development Stage

About the Company

康龙化成(宁波)生物医药有限公司(康龙生物)位于宁波前湾新区,业务覆盖大分子和细胞与基因治疗服务,剑指*的CGT(细胞与基因治疗)药物研发生产平台。凭借在生物医药研发服务领域的突出表现,公司连续入选2025年、2026年浙江省独角兽企业系列榜单,估值超过10亿美元,是前湾新区生物医药产业的标杆企业。

产品与服务
公司业务覆盖大分子和细胞与基因治疗服务,包括大分子药物发现及开发与生产服务(CDMO)和细胞与基因治疗实验室服务及基因治疗药物开发与生产服务(CDMO)。

荣誉资质
公司入选2025年浙江省独角兽企业系列榜单,是榜单内*一家生命健康领域的独角兽企业;2026年再次入选浙江独角兽企业榜单,为全省仅有的58家独角兽企业之一。

(本介绍内容由 DeepSeek AI 智能生成,仅供参考。)

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

How Fast Is Hiring Growing? (1 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Down 43%
  • 2024: Down 19%
  • 2023: Down 58%
  • 2022: Down 16%
Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Campus Recruitment & Advanced Degree Talent Demand
Master's 1
Note: How fast is hiring at 康龙化成(宁波)生物医药有限公司 growing? 2026: 5 openings (down 71%), 2025: 17 openings (down 43%), 2024: 30 openings (down 19%), 2023: 37 openings (down 58%), 2022: 88 openings (down 16%), 2021: 105 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Down 71%
  • 2024: Up 75%
Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at 康龙化成(宁波)生物医药有限公司 growing? Master's recruitment over the years: 2025: 2 openings (down 71%), 2024: 7 openings (up 75%), 2023: 4 openings, 2021: 3 openings.

Doctoral Degree Job Demand Analysis

(More)
N/A
Growth Rate
Doctoral Hiring by Year: 2026
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at 康龙化成(宁波)生物医药有限公司 growing? Doctorate recruitment over the years: 2026: 1 openings (down 50%), 2024: 1 openings (up 75%), 2023: 1 openings, 2021: 1 openings.

— What Are the Salaries Like? (14 records)

Manage
salary range: 8K - 50K, 92.8% of roles pay ¥8-30K
Note: salary statistics are based on 14 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 康龙化成(宁波)生物医药有限公司?92.8% of positions earn 8-30K, Undergraduate salary: ¥。工厂生产类 average salary ¥11.8K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Related Industry Tags

Job Category

  • 工厂生产类
    50% of total 50%
  • 质量管理类
    35.7% of total 35.7%
  • 生物/制药/化工/环保类
    28.6% of total 28.6%
  • 技工类
    21.4% of total 21.4%

Education

  • 本科
    71.4% of total 71.4%
  • 硕士
    14.3% of total 14.3%
  • 大专
    7.1% of total 7.1%
  • 博士
    7.1% of total 7.1%

Experience

  • 不限
    78.6% of total 78.6%
  • 5-10年
    14.3% of total 14.3%
  • 3-5年
    7.1% of total 7.1%
View Detailed Analysis

What does 康龙化成(宁波)生物医药有限公司 require? Who is 康龙化成(宁波)生物医药有限公司 hiring? recruitment: 工厂生产类占比最多占50%,其次是质量管理类占35.7%. What education can get in at ? 本科占比最多占71.4%,其次是硕士占14.3%. High education required at ? 硕士占14.3%,博士占7.1%. Work experience required at ? 不限占比最多占78.6%,其次是5-10年占14.3%. Where are the job locations at ? 宁波占比最多占100%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 348,740.5209万(元)
Legal Representative: 楼柏良
Date Established:
Credit Code: 91330201MA2H8JR46W
Registered Address: 浙江省宁波杭州湾新区滨海四路800号1号楼109室

Partners & Suppliers

双方达成战略合作,在生物药研发与生产领域开展合作,康龙化成(宁波)生物医药有限公司为臻格生物提供CDMO服务。 Source
合作客户 生物药CDMO服务

People who follow this company also follow

Competitors (Similar Companies)

“Helping partners successfully develop new drugs, reducing R&D costs an”
新药研发 生命科学 SMO CRO
制药/药业 医药 医药中间体 中间体
“主营医药中间体、原料药和成品药的研发、生产与销售”
医药 生物制品 生物医药 疫苗
临床研究 药物研发 新药研发 转化医学
功能食品 生产 化妆品 日化
医药 生物医药 生物信息 单细胞测序
新药研发 CRO 动物实验 气质联用
“为化工事业往生物方向的绿色转型尽一份力”
“An innovative biopharmaceutical enterprise focusing on antibody drugs”
“Trustworthy overall solution provider for medical systems”
医药 干细胞 药物研发 高通量筛选
生物科技/生物工程 抗体 生物医药 多肽
农业 农作物种子 生产 种业

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates